Theravance Biopharma, Inc. Increase (Decrease) in Other Operating Assets
Theravance Biopharma, Inc. (TBPH) reported Increase (Decrease) in Other Operating Assets of -$1.36 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-08-11
- Theravance Biopharma, Inc. increase (decrease) in other operating assets for the quarter ending 2026-06-30 was -$331.00K, a 126.59% decline year-over-year.
- Theravance Biopharma, Inc. increase (decrease) in other operating assets for the quarter ending 2026-03-31 was -$1.02M.
- Theravance Biopharma, Inc. increase (decrease) in other operating assets for the quarter ending 2025-12-31 was -$251.00K, a 305.74% decline year-over-year.
- Theravance Biopharma, Inc. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was $413.00K.
- Theravance Biopharma, Inc. increase (decrease) in other operating assets for fiscal 2025 was $1.08M.
- Theravance Biopharma, Inc. increase (decrease) in other operating assets for fiscal 2024 was -$411.00K, a 133.33% decline from fiscal 2023.
- Theravance Biopharma, Inc. increase (decrease) in other operating assets for fiscal 2023 was $1.23M, a 67.57% decline from fiscal 2022.
- Theravance Biopharma, Inc. increase (decrease) in other operating assets for fiscal 2022 was $3.80M, a 291.15% increase from fiscal 2021.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 6 month as first filed | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 9 month as first filed | Increase (Decrease) in Other Operating Assets 12 month | Increase (Decrease) in Other Operating Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$331.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$1.36M 10-Q · filed 2026-08-11 | -$1.61M derived: sum of 3 quarters · filed 2026-08-11 | -$1.19M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2026-03-31 | -$1.02M 10-Q · filed 2026-05-07 | -$1.28M derived: sum of 2 quarters · filed 2026-05-07 | -$863.00K derived: sum of 3 quarters · filed 2026-05-07 | $382.00K derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-12-31 | -$251.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $162.00K derived: sum of 2 quarters · filed 2026-03-23 | $1.41M derived: sum of 3 quarters · filed 2026-08-11 | $1.08M 10-K · filed 2026-03-23 | |||
| 2025-09-30 | $413.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.66M derived: sum of 2 quarters · filed 2026-08-11 | $1.33M 10-Q · filed 2025-11-12 | $1.45M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-06-30 | $1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $915.00K 10-Q · filed 2026-08-11 | $1.04M derived: sum of 3 quarters · filed 2026-08-11 | $796.00K derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-03-31 | -$330.00K 10-Q · filed 2026-05-07 | -$208.00K derived: sum of 2 quarters · filed 2026-05-07 | -$449.00K derived: sum of 3 quarters · filed 2026-05-07 | -$593.00K derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | $122.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$119.00K derived: sum of 2 quarters · filed 2026-03-23 | -$263.00K derived: sum of 3 quarters · filed 2026-03-23 | -$411.00K 10-K · filed 2026-03-23 | |||
| 2024-09-30 | -$241.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$385.00K derived: sum of 2 quarters · filed 2025-11-12 | -$533.00K 10-Q · filed 2025-11-12 | $4.01M derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | -$144.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$292.00K 10-Q · filed 2025-08-13 | $4.25M derived: sum of 3 quarters · filed 2025-08-13 | $2.69M derived: sum of 4 quarters · filed 2025-08-13 | |||
| 2024-03-31 | -$148.00K 10-Q · filed 2025-05-12 | $4.39M derived: sum of 2 quarters · filed 2025-05-12 | $2.84M derived: sum of 3 quarters · filed 2025-05-12 | $2.35M derived: sum of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | $4.54M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $2.98M derived: sum of 2 quarters · filed 2025-03-07 | $2.50M derived: sum of 3 quarters · filed 2025-03-07 | $1.23M 10-K · filed 2025-03-07 | |||
| 2023-09-30 | -$1.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$2.04M derived: sum of 2 quarters · filed 2024-11-14 | -$3.31M 10-Q · filed 2024-11-14 | -$1.25M derived: sum of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | -$481.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$1.75M 10-Q · filed 2024-08-08 | $308.00K derived: sum of 3 quarters · filed 2024-08-08 | $1.91M derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | -$1.27M 10-Q · filed 2024-05-15 | $789.00K derived: sum of 2 quarters · filed 2024-05-15 | $2.39M derived: sum of 3 quarters · filed 2024-05-15 | $2.53M derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | $2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $3.66M derived: sum of 2 quarters · filed 2024-03-01 | $3.80M derived: sum of 3 quarters · filed 2024-03-01 | $3.80M 10-K · filed 2024-03-01 | |||
| 2022-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.74M derived: sum of 2 quarters · filed 2023-11-09 | $1.74M 10-Q · filed 2023-11-09 | $1.71M derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | $146.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $145.00K 10-Q · filed 2023-08-09 | $111.00K derived: sum of 3 quarters · filed 2023-08-09 | $2.11M derived: sum of 4 quarters · filed 2023-08-09 | |||
| 2022-03-31 | -$1.00K 10-Q · filed 2023-05-10 | -$35.00K derived: sum of 2 quarters · filed 2023-05-10 | $1.97M derived: sum of 3 quarters · filed 2023-05-10 | $1.04M derived: sum of 4 quarters · filed 2023-05-10 | |||
| 2021-12-31 | -$34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.97M derived: sum of 2 quarters · filed 2023-03-01 | $1.04M derived: sum of 3 quarters · filed 2023-03-01 | $972.00K 10-K · filed 2023-03-01 | |||
| 2021-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.07M derived: sum of 2 quarters · filed 2022-11-09 | $1.01M 10-Q · filed 2022-11-09 | $2.69M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-06-30 | -$932.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$997.00K 10-Q · filed 2022-08-08 | $691.00K derived: sum of 3 quarters · filed 2023-03-01 | -$260.00K derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-03-31 | -$65.00K 10-Q · filed 2022-05-06 | $1.62M derived: sum of 2 quarters · filed 2023-03-01 | $672.00K derived: sum of 3 quarters · filed 2023-03-01 | $946.00K derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2020-12-31 | $1.69M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $737.00K derived: sum of 2 quarters · filed 2023-03-01 | $1.01M derived: sum of 3 quarters · filed 2023-03-01 | $1.11M 10-K · filed 2023-03-01 | $852.00K 10-K · filed 2021-02-26 | ||
| 2020-09-30 | -$951.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$677.00K derived: sum of 2 quarters · filed 2021-11-08 | -$578.00K 10-Q · filed 2021-11-08 | -$541.00K 10-Q · filed 2020-11-09 | -$217.00K derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-06-30 | $274.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $373.00K 10-Q · filed 2021-08-05 | $73.00K 10-Q · filed 2020-08-10 | $734.00K derived: sum of 3 quarters · filed 2022-02-28 | $733.00K derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-03-31 | $99.00K 10-Q · filed 2021-05-06 | $460.00K derived: sum of 2 quarters · filed 2022-02-28 | $459.00K derived: sum of 3 quarters · filed 2022-02-28 | ||||
| 2019-12-31 | $361.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $360.00K derived: sum of 2 quarters · filed 2022-02-28 | $358.00K 10-K · filed 2022-02-28 | ||||
| 2019-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$3.00K 10-Q · filed 2020-11-09 | |||||
| 2019-06-30 | -$2.00K 10-Q · filed 2020-08-10 | ||||||
| 2018-12-31 | -$160.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$86.00K derived: sum of 2 quarters · filed 2021-02-26 | -$45.00K 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | $74.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $115.00K 10-Q · filed 2019-11-08 | |||||
| 2018-06-30 | $41.00K 10-Q · filed 2019-08-05 | ||||||
| 2017-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $226.00K derived: sum of 2 quarters · filed 2020-02-27 | $620.00K derived: sum of 3 quarters · filed 2020-02-27 | $354.00K 10-K · filed 2020-02-27 | |||
| 2017-09-30 | $221.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $615.00K derived: sum of 2 quarters · filed 2018-11-08 | $349.00K 10-Q · filed 2018-11-08 | -$3.54M derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2017-06-30 | $394.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $128.00K 10-Q · filed 2018-08-02 | -$3.76M derived: sum of 3 quarters · filed 2019-02-28 | $655.00K derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2017-03-31 | -$266.00K 10-Q · filed 2018-05-09 | -$4.16M derived: sum of 2 quarters · filed 2019-02-28 | $261.00K derived: sum of 3 quarters · filed 2019-02-28 | -$195.00K derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2016-12-31 | -$3.89M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $527.00K derived: sum of 2 quarters · filed 2019-02-28 | $71.00K derived: sum of 3 quarters · filed 2019-02-28 | -$184.00K 10-K · filed 2019-02-28 | |||
| 2016-09-30 | $4.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $3.96M derived: sum of 2 quarters · filed 2017-11-08 | $3.71M 10-Q · filed 2017-11-08 | $3.86M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2016-06-30 | -$456.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$711.00K 10-Q · filed 2017-08-09 | -$554.00K derived: sum of 3 quarters · filed 2018-02-28 | -$650.00K derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2016-03-31 | -$255.00K 10-Q · filed 2017-05-10 | -$98.00K derived: sum of 2 quarters · filed 2018-02-28 | -$194.00K derived: sum of 3 quarters · filed 2018-02-28 | $137.00K derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2015-12-31 | $157.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $61.00K derived: sum of 2 quarters · filed 2018-02-28 | $392.00K derived: sum of 3 quarters · filed 2018-02-28 | $572.00K 10-K · filed 2018-02-28 | |||
| 2015-09-30 | -$96.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $235.00K derived: sum of 2 quarters · filed 2016-11-09 | $415.00K 10-Q · filed 2016-11-09 | $626.00K derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-06-30 | $331.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $511.00K 10-Q · filed 2016-08-09 | $722.00K derived: sum of 3 quarters · filed 2017-03-01 | $722.00K derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-03-31 | $180.00K 10-Q · filed 2016-05-10 | $391.00K derived: sum of 2 quarters · filed 2017-03-01 | $391.00K derived: sum of 3 quarters · filed 2017-03-01 | $391.00K derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2014-12-31 | $211.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $211.00K derived: sum of 2 quarters · filed 2017-03-01 | $211.00K derived: sum of 3 quarters · filed 2017-03-01 | $211.00K 10-K · filed 2017-03-01 | |||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $0.00 derived: sum of 2 quarters · filed 2015-11-12 | $0.00 10-Q · filed 2015-11-12 | ||||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $0.00 10-Q · filed 2015-08-13 | |||||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-13 | ||||||
| 2013-12-31 | $0.00 10-K · filed 2016-03-11 | ||||||
| 2012-12-31 | $0.00 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |